Analysis of type T1 and T2 cytokines in patients with prostate cancer

被引:1
|
作者
Filella, X
Alcover, J
Zarco, MA
Beardo, P
Molina, R
Ballesta, AM
机构
[1] Hosp Clin Barcelona, Canc Res Unit, Dept Clin Biochem, Inst Invest Biomed August Pi I Sunyer, Barcelona 08036, Spain
[2] Hosp Clin Barcelona, Dept Urol, Inst Invest Biomed August Pi I Sunyer, Barcelona 08036, Spain
来源
PROSTATE | 2000年 / 44卷 / 04期
关键词
prostate cancer; cytokine; Th1-Th2; paradigm;
D O I
10.1002/1097-0045(20000901)44:4<271::AID-PROS2>3.0.CO;2-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. It has been proposed that a dysregulation in the balance between type T1 (IL-2, IFN-gamma) and type T2 (IL-4, IL-10) cytokines may be implicated in the development of cancer. METHODS. We determined the expression of IL-2, IL-4, IL-10, and IFN-gamma in CD4 and CD8 lymphocytes by flow cytometry in 12 patients with prostate cancer and in 7 healthy subjects. In addition to the basal expression of these cytokines, their expression was also determined, following stimulation of lymphocytes with PMA (phorbol 12-mystirate 13 acetate) and ionomycin. RESULTS. The basal expression of cytokines was scarce, while following stimulation this increased markedly. On the other hand, there was a dysregulation in the balance between T1 and T2 lymphocytes in patients with prostate cancer. To this effect, in relation to healthy subjects, we observed an increase in IL-10 expression and a decrease in IL-2 expression. CONCLUSIONS. The disequilibrium observed in the balance between type T1 and type T2 cytokines may be implicated in the evolution of neoplastic disease. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 50 条
  • [1] Different basal expression of type T1 and T2 cytokines in peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate
    Elsässer-Beile, U
    Gierschner, D
    Jantscheff, P
    Schultze-Seemann, W
    Katzenwadel, A
    Wetterauer, U
    ANTICANCER RESEARCH, 2003, 23 (5A) : 4027 - 4031
  • [2] Management of the neck in patients with T1 and T2 cancer in the mouth
    Smith, GI
    O'Brien, CJ
    Clark, J
    Shannon, KF
    Clifford, AR
    McNeil, EB
    Gao, K
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2004, 42 (06): : 494 - 500
  • [3] Role of T1 and T2 cytokines in the response to Mycobacterium tuberculosis
    Flynn, JL
    Bloom, BR
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 137 - 146
  • [4] Morbidity adapted therapy of localised prostate cancer (stage T1 and T2)
    Brookman-Amissah, S.
    Klotz, T.
    Hofstaedter, F. .
    Gerken, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 301 - 301
  • [5] Influencing factors for mortality in prostate cancer patients with T1 and T2 stage: a retrospective cohort study
    Hong, Xuwei
    Cao, Sizhe
    Chi, Zepai
    Zhang, Yuanfeng
    Lin, Tianxin
    Zhang, Yonghai
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (01) : 58 - 70
  • [6] Repeatability of quantitative MR fingerprinting for T1 and T2 measurements of metastatic bone in prostate cancer patients
    Rata, Mihaela
    Orton, Matthew R.
    Tunariu, Nina
    Curcean, Andra
    Hughes, Julie
    Scurr, Erica
    Blackledge, Matthew
    d'Arcy, James
    Jiang, Yun
    Gulani, Vikas
    Koh, Dow-Mu
    EUROPEAN RADIOLOGY, 2024,
  • [7] Outcomes of radiotherapy in patients with glottic larynx cancer T1 and T2
    Jesús M Flores
    Maria A Poitevín
    Luis F Oñate
    BMC Cancer, 7 (Suppl 1)
  • [8] Does human toxoplasmosis involve an imbalance in T1/T2 cytokines?
    Marin, JEG
    Pinon, JM
    Bonhomme, A
    Guenounou, M
    MEDICAL HYPOTHESES, 1997, 48 (02) : 161 - 169
  • [9] PERINEAL VERSUS RETROPUBIC RADICAL PROSTATECTOMY FOR T1, T2 PROSTATE-CANCER
    HAAB, F
    BOCCONGIBOD, L
    DELMAS, V
    BOCCONGIBOD, L
    TOUBLANC, M
    BRITISH JOURNAL OF UROLOGY, 1994, 74 (05): : 626 - 629
  • [10] BETWEEN T1 AND T2
    WILANSKY, A
    AMERICAN MATHEMATICAL MONTHLY, 1967, 74 (03): : 261 - &